Winlevi just got FDA approval, projected to be available early 2021 in the US
    Treatment 8/27/2020

    At a glance
    In this general discussion post, the primary subjects mentioned are
    💧 Clascoterone (Winlevi) (topical) 1-2%
    💧 RU58841 (topical) less than a month
    💧 Minoxidil (topical) 2x daily a couple of days
    💊 Dutasteride (oral) 1mg daily 1 year
    💊 Finasteride (oral) 1mg Mon/Wed/Fri 4 years
    the tone is 😐 neutral.

    Other terms

    The conversation is about creating a higher concentration of the newly FDA-approved hair loss treatment, Clascoterone (Winlevi), through compounding pharmacies and possibly organizing group purchases. Some users are unfamiliar with Winlevi and are asking for an explanation of the drug.
    View this post in the Community →

    Similar Community Posts Join

    6 / 97 results

      community Pyrludimide (KX-826) or Breezula (clascoterone)

      in Treatment  8 upvotes 2 days ago
      The conversation is about hair loss treatments, specifically Pyrludimide (KX-826) and Breezula (clascoterone), with the user unable to tolerate finasteride and dutasteride. The user plans to use these treatments alongside minoxidil, considering the efficacy and availability of each option.

      community Winlevi coming out in 2019

       13 upvotes 7 years ago
      The conversation discusses the potential release of Winlevi in 2019 by Cassiopeia for hair loss treatment. It suggests a regimen combining minoxidil, Winlevi, Nizoral, and possibly dermarolling, with a comment mentioning Breezula as an alternative to finasteride without side effects.

      community Clascoterone - Why are there so few posts if it’s already on the market?

      in Chat  33 upvotes 2 months ago
      Clascoterone is being discussed for hair loss, but its current acne formulation may not be suitable for scalp use due to potential skin irritation and lower dosage compared to Breezula. Users mention other treatments like finasteride, minoxidil, and pyrilutamide, with some expressing skepticism about clascoterone's effectiveness for hair loss.

      community Cosmo Pharma Lists Breezula Phase 3 Trial on ClinicalTrials.gov

      in Research/Science  27 upvotes 2 years ago
      A phase 3 trial for Breezula (clascoterone solution) to treat male pattern hair loss has been listed, with 726 participants and a completion date of January 2025. Other treatments mentioned include Aneira Pharma's combination of minoxidil and latanoprost, Triple Hair's combination of minoxidil, latanoprost, and finasteride, and a new microneedling and LLLT device called StimuSIL.

      community BREEZULA COVID UPDATE: Filing for Special Protocol Assessment with FDA

      in Research/Science  63 upvotes 5 years ago
      The conversation discusses the progress of Clascoterone (Breezula) for hair loss treatment, noting that COVID-19 delayed female trials by three months but Phase III trials for males are proceeding with a Special Protocol Assessment filed with the FDA. Users express hope for Breezula as an alternative to existing treatments like finasteride and minoxidil, despite concerns about its potential high cost.

    Related Research

    6 / 13 results